Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CKS1B | P61024 | 1/20 | 0.31 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
| ▸ | COMT | P21964 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13320394 | 1.00 | MEN1 (0.32) | MEN1USP2MAPTHTTRECQL | |
| SCHEMBL4745895 | 0.87 | BCHE (0.33) | BCHE | |
| SCHEMBL13320387 | 0.86 | CYP17A1 (0.32) | MEN1MAPTRECQLKMT2A | |
| SCHEMBL13320386 | 0.86 | CYP17A1 (0.32) | MEN1MAPTRECQLKMT2A | |
| SCHEMBL13320392 | 0.85 | HPGD (0.36) | MEN1KMT2ACKS1BSKP2 | |
| SCHEMBL13320393 | 0.85 | HPGD (0.36) | MEN1KMT2ACKS1BSKP2 | |
| SCHEMBL4746263 | 0.82 | CYP17A1 (0.31) | BCHE | |
| SCHEMBL4746261 | 0.82 | CYP17A1 (0.31) | BCHE | |
| SCHEMBL4745880 | 0.81 | MAPT (0.34) | MEN1USP2MAPTHTTRECQL | |
| SCHEMBL13320347 | 0.80 | CCR1 (0.39) | MEN1MAPTHTTRECQLKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8431244-B2 | Indenochrysene derivative and organic light-emitting device using same | CANON KABUSHIKI KAISHA (JP) | 2013-04-30 | — | — | US | disclosed |
| US-8431244-B2 | Indenochrysene derivative and organic light-emitting device using same | CANON KABUSHIKI KAISHA (JP) | 2013-04-30 | — | — | US | disclosed |
| US-20100127618-A1 | INDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | CANON KABUSHIKI KAISHA (JP) | 2010-05-27 | — | — | US | disclosed |
| US-20100127618-A1 | INDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | CANON KABUSHIKI KAISHA (JP) | 2010-05-27 | — | — | US | disclosed |
| WO-2008146720-A1 | INDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | CANON KABUSHIKI KAISHA (JP) | 2008-12-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100127618-A1 | INDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | OR51E2, INTS9, ORAI2 | MEN1 1271/4885USP2 3765/4885MAPT 1028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.